{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:19:42Z","timestamp":1784650782616,"version":"3.55.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["12473 (2020-2023)"],"award-info":[{"award-number":["12473 (2020-2023)"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["AJOB Empirical Bioethics"],"published-print":{"date-parts":[[2022,10,2]]},"DOI":"10.1080\/23294515.2022.2110963","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T12:43:13Z","timestamp":1661517793000},"page":"275-286","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Physicians\u2019 Perspectives on Ethical Issues Regarding Expensive Anti-Cancer Treatments: A Qualitative Study"],"prefix":"10.1080","volume":"13","author":[{"given":"Charlotte H. C.","family":"Bomhof","sequence":"first","affiliation":[{"name":"Department of Medical Ethics, Philosophy and History of Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-9659","authenticated-orcid":false,"given":"Maartje","family":"Schermer","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics, Philosophy and History of Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sleijfer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-6222","authenticated-orcid":false,"given":"Eline M.","family":"Bunnik","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics, Philosophy and History of Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28040254"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2017.03.006"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.17.00001"},{"key":"CIT0004","volume-title":"Principles of biomedical ethics","author":"Beauchamp T. L","year":"2019"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/s11673-021-10090-710.1007\/s11673-021-10090-7"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2017.1315294"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21443"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.08.005"},{"key":"CIT0010","unstructured":"Dutch National Institute for Public Health and the Environment. 2018. Public health foresight report 2018. 1\u201336."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7524.1075"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000170esmoopen-2017-000170"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.7793"},{"key":"CIT0014","unstructured":"Parfit, D. 1991. \u201cEquality or Priority.\u201d The Lindley Lecture, University of Texas"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.56"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2115297"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.07.007"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082313"},{"key":"CIT0020","unstructured":"Vereniging Innovatieve Geneesmiddelen. 2020. Nederlandse pati\u00ebnt wacht te lang op nieuwe medicijnen. (in Dutch) https:\/\/www.vereniginginnovatievegeneesmiddelen.nl\/actueel\/nederlandse-patient-wacht-te-lang-op-nieuwe-medicijnen (Website, access date 29-09-2021)"},{"key":"CIT0021","unstructured":"Zorginstituut. 2020. Beoordelingsprocedure specialistische geneesmiddelen. 1\u201316. (in Dutch)"},{"key":"CIT0022","unstructured":"Zorginstituut Nederland. n.d. Mission Statement. Accessed May 1, 2021. https:\/\/www.zorginstituutnederland.nl\/over-ons\/organisatie\/missie (in Dutch)."},{"key":"CIT0023","unstructured":"Zorginstituut Nederland. 2015. Pakketadvies sluisgeneesmiddel nivolumab (Opdivo\u00ae) bij gevorderde (plaveiselcel) niet-kleincellige longkanker. (in Dutch)"},{"key":"CIT0024","unstructured":"Zorginstituut Nederland. 2021. Overzicht sluismiddelen waarover het Zorginstituut heeft geadviseerd. Accessed March 30, 2022. https:\/\/www.zorginstituutnederland.nl\/over-ons\/programmas-en-samenwerkingsverbanden\/horizonscan-geneesmiddelen\/sluis-voor-dure-geneesmiddelen\/overzicht-sluismiddelen-waarover-het-zorginstituut-heeft-geadviseerd."}],"container-title":["AJOB Empirical Bioethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/23294515.2022.2110963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:45:57Z","timestamp":1666799157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/23294515.2022.2110963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10,2]]}},"alternative-id":["10.1080\/23294515.2022.2110963"],"URL":"https:\/\/doi.org\/10.1080\/23294515.2022.2110963","relation":{},"ISSN":["2329-4515","2329-4523"],"issn-type":[{"value":"2329-4515","type":"print"},{"value":"2329-4523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=uabr21","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=uabr21","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}